Geoffrey S Harris

Geoffrey S. Harris is a notable inventor based in Cardiff, CA (US). He has made significant contributions to the field of pharmacology, particularly in the development of V1a receptor agonists. With a total of 2 patents, his work focuses on innovative compounds that have the potential to address serious medical conditions.

Latest Patents

Harris's latest patents include the development of V1a receptor agonists, which are described as compounds of formula (I), along with their salts and compositions. These compounds are particularly useful as V1a vasopressin agonists for treating complications of cirrhosis, such as bacterial peritonitis, HRS2, and refractory ascites. His research aims to provide new therapeutic options for patients suffering from these challenging conditions.

Career Highlights

Throughout his career, Geoffrey S. Harris has been associated with Ferring B.V., a company known for its commitment to advancing healthcare through innovative solutions. His work has not only contributed to the scientific community but has also paved the way for new treatment methodologies in the medical field.

Collaborations

Harris has collaborated with esteemed colleagues, including Kazimierz Wisniewski and Robert Felix Galyean. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Geoffrey S. Harris stands out as a prominent inventor in the realm of pharmacology, with his innovative work on V1a receptor agonists. His contributions are vital for advancing treatment options for serious medical conditions, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.